Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancer

Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancer

Bing-Lei Ma,1,2,* Lin Yao,1,2,* Yu Fan,1,2 Yu Wang,1,2 Yi-Sen Meng,1,2 Qian Zhang,1,2 Zhi-Song He,1,2 Jie Jin,1,2 Li-Qun Zhou1,21Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China; 2Beijing Key Laboratory of...

Full description

Bibliographic Details
Main Authors: Ma BL, Yao L, Fan Y, Wang Y, Meng YS, Zhang Q, He ZS, Jin J, Zhou LQ
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Cancer Management and Research
Subjects:
localized high-risk
limited advanced
prostate cancer
neoadjuvant hormone therapy
short-term benefit
Online Access:https://www.dovepress.com/short-term-benefit-of-neoadjuvant-hormone-therapy-in-patients-with-loc-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/short-term-benefit-of-neoadjuvant-hormone-therapy-in-patients-with-loc-peer-reviewed-article-CMAR

Similar Items